STEFAN CHESBRO: Open Payments
NPI 1093214421 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 21 payments from 10 companies in 2025. Trend: 2023 $99 · 2024 $532 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $101 |
| Novo Nordisk Inc | 4 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $87 |
| PFIZER INC. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24 |
| Edwards Lifesciences Corporation | 1 | $23 |
| Abbott Laboratories | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $16 |
Products named: LEQVIO, JARDIANCE, Wegovy, ELIQUIS, Kerendia, Ozempic, LifeVest, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV).
Industry payments across CA — which companies pay providers there.
